Skip to main content
Year archive

SinoMab BioScience Limited — 2022 filings

All 50 regulatory filings released by SinoMab BioScience Limited (3681) in 2022, sourced directly from the official regulator.

50 Filings
2022 Period
2022 filings (50)
Filing Released Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-12-05 English
CONNECTED TRANSACTION SUPPLEMENTAL LEASE AGREEMENT
Regulatory Filings
2022-12-01 English
CHANGE OF COMPANY SECRETARY
Regulatory Filings
2022-11-17 English
Next Day Disclosure Return
Regulatory Filings
2022-11-16 English
COMPLETION OF SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2022-11-16 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2022-11-07 English
GRANT OF SHARE OPTIONS
Regulatory Filings
2022-11-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-11-03 English
SUBSCRIPTIONS OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2022-11-02 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 26 OCTOBER 2022
Regulatory Filings
2022-10-26 English
2022 SHARE OPTION SCHEME
Regulatory Filings
2022-10-06 English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD AT THEATER R2, 10/F, UNITED CENTRE, 95 QUEENSWAY, ADMIRALTY, HONG KONG ON WEDNESDAY, 26 OCTOBER 2022 AT 10:00 A.M.
Regulatory Filings
2022-10-06 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2022-10-06 English
PROPOSAL FOR ADOPTION OF THE 2022 SHARE OPTION SCHEME AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2022-10-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-10-05 English
Interim Report 2022
Regulatory Filings
2022-09-27 English
PROPOSED ADOPTION OF SHARE OPTION SCHEME
Regulatory Filings
2022-09-19 English
POSTPONEMENT OF EXTRAORDINARY GENERAL MEETING AND WITHDRAWAL OF THE ORDINARY RESOLUTION
Regulatory Filings
2022-09-14 English
VOLUNTARY ANNOUNCEMENT UPDATE IN CLINICAL PROGRESS
Regulatory Filings
2022-09-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-09-05 English
2022 SHARE OPTION SCHEME
Regulatory Filings
2022-08-30 English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD AT THEATER R2, 10/F, UNITED CENTRE, 95 QUEENSWAY, ADMIRALTY, HONG KONG ON WEDNESDAY, 21 SEPTEMBER 2022 AT 10:00 A.M.
Regulatory Filings
2022-08-30 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2022-08-30 English
PROPOSAL FOR ADOPTION OF THE 2022 SHARE OPTION SCHEME AND NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings
2022-08-30 English
VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR SN1011 BY NMPA
Regulatory Filings
2022-08-23 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
Regulatory Filings
2022-08-22 English
CHANGE OF ADDRESS OF REGISTERED OFFICE
Regulatory Filings
2022-08-22 English
DATE OF BOARD MEETING
Regulatory Filings
2022-08-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-08-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-07-05 English
VOLUNTARY ANNOUNCEMENT FIRST HEALTHY SUBJECT DOSED IN A PHASE I CLINICAL TRIAL OF SM17 IN THE U.S.
Regulatory Filings
2022-06-15 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Regulatory Filings
2022-06-13 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 13 JUNE 2022 AND RETIREMENT OF NON-EXECUTIVE DIRECTOR
Regulatory Filings
2022-06-13 English
VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
Regulatory Filings
2022-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Regulatory Filings
2022-05-04 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-04-27 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD AT THEATER R1, 10/F, UNITED CENTRE, 95 QUEENSWAY, ADMIRALTY, HONG KONG ON MONDAY, 13 JUNE 2022 AT 10:00 A.M.
Regulatory Filings
2022-04-27 English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE SHARES AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-04-27 English
Annual Report 2021
Regulatory Filings
2022-04-27 English
VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR SN1011 BY NMPA
Regulatory Filings
2022-04-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-04 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021 AND CHANGE IN USE OF PROCEEDS
Regulatory Filings
2022-03-21 English
VOLUNTARY ANNOUNCEMENT IND APPROVAL FOR SM17 BY FDA
Regulatory Filings
2022-03-14 English
DATE OF BOARD MEETING
Regulatory Filings
2022-03-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-03-02 English
VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SM17 ACCEPTED BY FDA
Regulatory Filings
2022-02-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-08 English
VOLUNTARY ANNOUNCEMENT IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
Regulatory Filings
2022-02-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-04 English